The Cellulite Reduction Formula by Futura, codenamed CRF100, is an alkaloid containing topically applied cream that comprises DermaSys delivery system.
CRF100 has demonstrated an eight-fold improvement in delivery of the alkaloid through the skin compared with other comparator products, in in vitro trials.
According to the company, DermaSys, that provides improved permeation, leads to a physiologically active dose of the alkaloid in the subcutaneous tissues.
Futura Medical said that CRF100 will be an over-the-counter product and will be licensed at an appropriate time to a major global company for commercialisation.